Is Qiagen (QIA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 17.5% / 30% | 14.2% / 30% | 5.7% / 30% | N/A | ✓ HALAL |
| DJIM | 17.5% / 33% | 14.2% / 33% | 5.7% / 33% | N/A | ✓ HALAL |
| MSCI | 24.9% / 33% | 20.3% / 33% | 8.1% / 33% | N/A | ✓ HALAL |
| S&P | 17.5% / 33% | 14.2% / 33% | 5.7% / 33% | N/A | ✓ HALAL |
| FTSE | 24.9% / 33% | 20.3% / 33% | 8.1% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 66.4% | |
| Operating Margin | 27.4% | |
| Net Margin | 20.3% | |
| Return on Equity (ROE) | 11.6% | |
| Return on Assets (ROA) | 5.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $674M |
| Free Cash Flow | $502M |
| Total Debt | $1.4B |
| Debt-to-Equity | 48.6 |
| Current Ratio | 3.9 |
| Total Assets | $5.7B |
Price & Trading
| Last Close | EUR 35.06 |
| 50-Day MA | EUR 40.59 |
| 200-Day MA | EUR 41.94 |
| Avg Volume | 655K |
| Beta | 0.7 |
|
52-Week Range
EUR 33.76
| |
About Qiagen (QIA)
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Qiagen (QIA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Qiagen is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Qiagen's debt ratio?
Qiagen's debt ratio is 17.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 24.9%.
What are Qiagen's key financial metrics?
Qiagen has a market capitalization of $7.0B, trailing P/E ratio of 19.2. The company maintains a gross margin of 66.4% and a net margin of 20.3%. Return on equity stands at 11.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.